Listen "Episode 27: Lessons Learned, COVID-19"
Episode Synopsis
For nearly 6 months, COVID-19 has raised numerous questions and concerns, as well as having led to global disruption. In addition to testing, TGen was an early adopter in tracking the virus to learn how it mutates and spreads. Joining TGen Talks to discuss what we've learned is Dr. David Engelthaler, co-director of TGen North, the Pathogen and Microbiome Division of TGen located in Flagstaff, Arizona.
Dr. Engelthaler discusses what the epidemiology is telling us about COVID-19, and how that plays into decisions states are making on whether to open, and if so, how broadly? He also discusses the global effort toward vaccine development, the possibility of a second wave of COVID-19 in the fall, lessons learned in terms of public health and how we prepare for other viruses in the future.
Dr. Engelthaler discusses what the epidemiology is telling us about COVID-19, and how that plays into decisions states are making on whether to open, and if so, how broadly? He also discusses the global effort toward vaccine development, the possibility of a second wave of COVID-19 in the fall, lessons learned in terms of public health and how we prepare for other viruses in the future.
More episodes of the podcast TGen Talks
Episode 87: From Deadly to Detectable?
30/10/2025
Liquid Biopsy TGT September
30/09/2025
Episode 85: Runway for Research
26/08/2025
Episode 84 Precision Medicine
29/07/2025
Episode 81: Accelerating Discovery to Market
30/04/2025
Episode 39: A TGen Overview
28/03/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.